HISTRELIN ACETATE

HISTRELIN ACETATE was reported 877 times

HISTRELIN ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPLICATION SITE GRANULOMA 1 0.5000
1 DELAYED MENARCHE 6 0.3529
2 PREMATURE MENARCHE 7 0.2258
3 IMPLANT SITE HYPERTROPHY 2 0.2222
4 EARLY MENARCHE 2 0.1429
5 ADMINISTRATION SITE SCAB 3 0.1154
6 IMPLANT SITE RASH 41 0.1145
7 IMPLANT SITE DERMATITIS 2 0.1111
8 PUBERTY 6 0.1053
9 MENARCHE 2 0.1053
10 INCISION SITE RASH 5 0.0833
11 BLOOD GONADOTROPHIN INCREASED 2 0.0800
12 DELAYED PUBERTY 19 0.0748
13 IMPLANT SITE URTICARIA 6 0.0612
14 GROWTH ACCELERATED 12 0.0556
15 IMPLANT SITE NODULE 2 0.0476
16 DEVICE EXTRUSION 9 0.0423
17 IMPLANT SITE PAPULES 1 0.0417
18 IMPLANT SITE VESICLES 6 0.0408
19 IMPLANT SITE PUSTULES 2 0.0328
20 BILATERAL BREAST BUDS 1 0.0294
21 SCAR INFLAMMATION 1 0.0286
22 IMPLANT SITE ABSCESS 5 0.0259
23 BLOOD LUTEINISING HORMONE INCREASED 6 0.0244
24 TESTICULAR HYPERTROPHY 1 0.0217
25 IMPLANT SITE IRRITATION 8 0.0211
26 FLUCTUANCE 1 0.0204
27 BLOOD LUTEINISING HORMONE ABNORMAL 1 0.0196
28 IMPLANT SITE DISCHARGE 7 0.0187
29 INJECTION SITE ABSCESS STERILE 2 0.0177
30 IMPLANT SITE INDURATION 2 0.0175
31 IMPLANT SITE CELLULITIS 4 0.0171
32 OESTRADIOL INCREASED 5 0.0166
33 IMPLANT SITE ERYTHEMA 16 0.0154
34 BLOOD FOLLICLE STIMULATING HORMONE ABNORMAL 1 0.0154
35 MEDICAL DEVICE SITE SCAB 1 0.0137
36 ABSCESS STERILE 2 0.0135
37 IMPLANT SITE PARAESTHESIA 2 0.0133
38 BRACHIAL PLEXUS INJURY 2 0.0124
39 RETINAL MIGRAINE 1 0.0123
40 INCISION SITE PRURITUS 1 0.0119
41 ASTROCYTOMA, LOW GRADE 2 0.0118
42 EXPULSION OF MEDICATION 6 0.0113
43 PROCEDURAL COMPLICATION 83 0.0108
44 LEUKODYSTROPHY 1 0.0108
45 IMPLANT SITE BRUISING 8 0.0107
46 IMPLANT SITE OEDEMA 1 0.0103
47 HEPATOBLASTOMA 1 0.0103
48 IMPLANT SITE INFECTION 23 0.0099
49 IMPLANT SITE SWELLING 10 0.0098
50 NEUROFIBROSARCOMA 1 0.0097
51 CORNEAL OPERATION 1 0.0097
52 ENCAPSULATION REACTION 1 0.0097
53 PITUITARY CYST 1 0.0090
54 IMPLANT SITE PRURITUS 8 0.0089
55 OSTEOCHONDROMA 1 0.0084
56 ULNAR NERVE INJURY 2 0.0083
57 IMPLANT SITE SCAR 6 0.0080
58 INSTILLATION SITE DISCOMFORT 1 0.0075
59 PRECOCIOUS PUBERTY 4 0.0070
60 IMPLANT SITE INFLAMMATION 2 0.0068
61 BREAST ENLARGEMENT 22 0.0067
62 IMPLANT SITE REACTION 3 0.0066
63 INCISION SITE SWELLING 2 0.0066
64 IMPLANT SITE DISCOLOURATION 1 0.0065
65 IMPLANT SITE WARMTH 1 0.0065
66 BREAST DISCOLOURATION 1 0.0063
67 APPLICATION SITE WOUND 1 0.0061
68 IMPLANT SITE PAIN 27 0.0060
69 BLOOD COPPER INCREASED 1 0.0056
70 ADMINISTRATION SITE DISCOMFORT 1 0.0053
71 IDIOPATHIC ORBITAL INFLAMMATION 1 0.0052
72 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 2 0.0051
73 ASTROCYTOMA 2 0.0051
74 IMPLANTATION COMPLICATION 1 0.0048
75 IMPLANT SITE HYPOAESTHESIA 1 0.0047
76 INCISION SITE ERYTHEMA 2 0.0043
77 BODY HEIGHT INCREASED 2 0.0041
78 EPIPHYSIOLYSIS 1 0.0040
79 SHORT STATURE 1 0.0038
80 MIGRATION OF IMPLANTED DRUG 2 0.0038
81 GROWTH DISORDER 1 0.0037
82 VICTIM OF ABUSE 1 0.0037
83 SHUNT MALFUNCTION 1 0.0035
84 IMPLANT SITE EROSION 1 0.0034
85 TEETHING 1 0.0033
86 BLOOD TESTOSTERONE INCREASED 7 0.0033
87 WOUND INFECTION PSEUDOMONAS 1 0.0032
88 IMMUNOGLOBULIN G4 RELATED DISEASE 1 0.0031
89 MENSTRUATION NORMAL 1 0.0030
90 PROCEDURAL ANXIETY 2 0.0029
91 PATIENT-DEVICE INCOMPATIBILITY 2 0.0029
92 HYPERALDOSTERONISM 1 0.0029
93 DEVICE BREAKAGE 117 0.0029
94 TRANSIENT GLOBAL AMNESIA 2 0.0028
95 INCORRECT PRODUCT ADMINISTRATION DURATION 60 0.0028
96 ADMINISTRATION SITE REACTION 1 0.0026
97 INCISION SITE COMPLICATION 2 0.0024
98 INCORRECT DRUG ADMINISTRATION DURATION 65 0.0023
99 SKIN LAXITY 1 0.0023
100 IMPLANT SITE HAEMORRHAGE 1 0.0023
101 THERAPEUTIC PRODUCT EFFECT PROLONGED 1 0.0022
102 DERMATITIS INFECTED 1 0.0020
103 IMPLANT SITE FIBROSIS 1 0.0020
104 SHUNT OCCLUSION 1 0.0020
105 KELOID SCAR 1 0.0019
106 MEDICAL DEVICE SITE PAIN 1 0.0018
107 OSTEOGENESIS IMPERFECTA 1 0.0017
108 INCISION SITE PAIN 2 0.0017
109 HAIR GROWTH ABNORMAL 11 0.0016
110 CORNEAL PERFORATION 1 0.0016
111 SEROMA 2 0.0016
112 SUTURE RELATED COMPLICATION 1 0.0014
113 ALPHA 1 FOETOPROTEIN INCREASED 1 0.0014
114 FAT TISSUE INCREASED 2 0.0014
115 WITHDRAWAL BLEED 1 0.0014
116 ATROPHIC VULVOVAGINITIS 1 0.0014
117 LEGAL PROBLEM 1 0.0014
118 PITUITARY TUMOUR 2 0.0013
119 TENDON DISCOMFORT 1 0.0013
120 INFECTION PARASITIC 1 0.0013
121 PRODUCT INEFFECTIVE 1 0.0013
122 IMPLANT SITE EXTRAVASATION 1 0.0013
123 WOUND DRAINAGE 1 0.0013
124 EXCESSIVE GRANULATION TISSUE 1 0.0012
125 INCISION SITE HAEMORRHAGE 1 0.0012
126 MYCOSIS FUNGOIDES 1 0.0012
127 OCULAR VASCULAR DISORDER 1 0.0012
128 WOUND DEHISCENCE 4 0.0012
129 PROTEIN URINE 1 0.0011
130 HUMAN CHORIONIC GONADOTROPIN INCREASED 1 0.0011
131 APPLICATION SITE DERMATITIS 1 0.0011
132 DERMATITIS CONTACT 12 0.0011
133 LIPOATROPHY 1 0.0011
134 INJECTION SITE SCAB 1 0.0010
135 ANTISOCIAL BEHAVIOUR 1 0.0010
136 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 1 0.0010
137 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
138 BONE NEOPLASM 1 0.0009
139 BLOOD TESTOSTERONE ABNORMAL 1 0.0009
140 COMPLEX PARTIAL SEIZURES 1 0.0009
141 THYROTOXIC CRISIS 1 0.0009
142 MOOD SWINGS 28 0.0009
143 MACROCYTOSIS 1 0.0009
144 OSTEOCHONDROSIS 1 0.0009
145 HORMONE LEVEL ABNORMAL 4 0.0008
146 GLUCOSE URINE PRESENT 1 0.0008
147 BRONCHIAL SECRETION RETENTION 1 0.0008
148 ENDOCRINE DISORDER 1 0.0008
149 IATROGENIC INJURY 1 0.0008
150 ENURESIS 3 0.0007
151 MENSTRUATION DELAYED 8 0.0007
152 PREMENSTRUAL SYNDROME 1 0.0007
153 COMPLICATION OF DEVICE REMOVAL 13 0.0007
154 MAST CELL ACTIVATION SYNDROME 1 0.0007
155 ACUTE ABDOMEN 1 0.0007
156 IMPETIGO 1 0.0007
157 POLYCYSTIC OVARIES 1 0.0006
158 URINE KETONE BODY PRESENT 1 0.0006
159 PITUITARY TUMOUR BENIGN 1 0.0006
160 BREAST MASS 4 0.0006
161 MILIARIA 1 0.0006
162 MEDICAL DEVICE REMOVAL 1 0.0006
163 TREATMENT DELAYED 1 0.0006
164 WOUND INFECTION STAPHYLOCOCCAL 1 0.0006
165 KYPHOSIS 1 0.0006
166 BREAST CYST 1 0.0006
167 HYPERTRICHOSIS 1 0.0005
168 INTERMENSTRUAL BLEEDING 3 0.0005
169 BLADDER SPASM 1 0.0005
170 SCAR 9 0.0005
171 AFFECT LABILITY 5 0.0005
172 DEVICE DISLOCATION 22 0.0005
173 DIPLEGIA 1 0.0005
174 NIPPLE PAIN 1 0.0005
175 VASCULAR OCCLUSION 1 0.0005
176 EAR SWELLING 1 0.0005
177 RASH GENERALISED 12 0.0005
178 HENOCH-SCHONLEIN PURPURA 1 0.0005
179 LIMB MASS 1 0.0005
180 PRODUCT LOT NUMBER ISSUE 1 0.0005
181 TEMPERATURE REGULATION DISORDER 1 0.0004
182 FEAR OF DEATH 1 0.0004
183 RASH PRURITIC 23 0.0004
184 VOLVULUS 1 0.0004
185 VIRAL UPPER RESPIRATORY TRACT INFECTION 2 0.0004
186 WEIGHT ABNORMAL 1 0.0004
187 DEVICE EXPULSION 27 0.0004
188 STARING 1 0.0004
189 PLATELET DISORDER 1 0.0004
190 VAGINAL DISCHARGE 4 0.0004
191 MEAN CELL VOLUME INCREASED 1 0.0004
192 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 2 0.0004
193 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
194 ADENOVIRUS INFECTION 1 0.0003
195 STRABISMUS 1 0.0003
196 GROWTH RETARDATION 1 0.0003
197 BRAIN HERNIATION 1 0.0003
198 CENTRAL VENOUS CATHETERISATION 1 0.0003
199 BRAIN NEOPLASM 3 0.0003
200 BRAIN DEATH 1 0.0003
201 PERSONALITY CHANGE 3 0.0003
202 DRUG EFFECT INCREASED 1 0.0003
203 APPLICATION SITE VESICLES 2 0.0003
204 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
205 DEAFNESS NEUROSENSORY 1 0.0003
206 NEOPLASM RECURRENCE 1 0.0003
207 DEVICE DEFECTIVE 5 0.0003
208 HYPOPNOEA 1 0.0003
209 EAR PRURITUS 1 0.0003
210 DEVICE PLACEMENT ISSUE 1 0.0003
211 PHARYNGITIS STREPTOCOCCAL 3 0.0003
212 DEVICE KINK 1 0.0003
213 CAROTID ARTERY OCCLUSION 1 0.0003
214 NERVE INJURY 3 0.0003
215 COMMUNICATION DISORDER 1 0.0003
216 PANIC DISORDER 1 0.0003
217 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
218 MOOD ALTERED 7 0.0003
219 CARDIOPULMONARY FAILURE 1 0.0003
220 SKIN ODOUR ABNORMAL 1 0.0003
221 UPPER LIMB FRACTURE 5 0.0003
222 GOITRE 1 0.0002
223 ERECTION INCREASED 1 0.0002
224 SELF-INJURIOUS IDEATION 1 0.0002
225 PSEUDOMONAS INFECTION 2 0.0002
226 CHAPPED LIPS 1 0.0002
227 AMENORRHOEA 4 0.0002
228 DYSPHEMIA 1 0.0002
229 PARONYCHIA 1 0.0002
230 GINGIVAL SWELLING 1 0.0002
231 BRAIN NEOPLASM MALIGNANT 1 0.0002
232 DRUG EFFECT DECREASED 12 0.0002
233 DRUG EFFECT DELAYED 1 0.0002
234 BLOOD PROLACTIN INCREASED 1 0.0002
235 RASH VESICULAR 1 0.0002
236 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
237 APPLICATION SITE SWELLING 1 0.0002
238 OVARIAN CYST 2 0.0002
239 AGGRESSION 10 0.0002
240 PATHOLOGICAL FRACTURE 1 0.0002
241 WEIGHT LOSS POOR 1 0.0002
242 FAILURE TO THRIVE 1 0.0002
243 RASH ERYTHEMATOUS 9 0.0002
244 BREAST PAIN 2 0.0002
245 OVERWEIGHT 1 0.0002
246 HIP SURGERY 1 0.0002
247 HYDROCEPHALUS 1 0.0002
248 TIC 1 0.0002
249 INTRACRANIAL PRESSURE INCREASED 1 0.0002
250 RASH PAPULAR 4 0.0002
251 ABNORMAL BEHAVIOUR 7 0.0002
252 SCAB 2 0.0002
253 NEUROLOGICAL SYMPTOM 1 0.0002
254 SKIN WARM 1 0.0002
255 TYPE 1 DIABETES MELLITUS 1 0.0002
256 DERMATITIS ACNEIFORM 1 0.0002
257 MENISCUS INJURY 1 0.0002
258 EMOTIONAL DISORDER 5 0.0002
259 SCOLIOSIS 1 0.0002
260 CYST 2 0.0002
261 DERMATITIS ALLERGIC 2 0.0002
262 DEVICE DEPLOYMENT ISSUE 2 0.0002
263 SOMNAMBULISM 1 0.0002
264 DYSMENORRHOEA 2 0.0002
265 SKIN MASS 1 0.0001
266 POST-TRAUMATIC STRESS DISORDER 1 0.0001
267 WEIGHT INCREASED 31 0.0001
268 SWELLING FACE 9 0.0001
269 BLINDNESS TRANSIENT 1 0.0001
270 MEDICAL DEVICE COMPLICATION 1 0.0001
271 CEREBRAL DISORDER 1 0.0001
272 RASH MACULO-PAPULAR 3 0.0001
273 SUNBURN 1 0.0001
274 BREAST TENDERNESS 1 0.0001
275 DEVICE FAILURE 2 0.0001
276 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
277 SEIZURE 15 0.0001
278 TRICUSPID VALVE INCOMPETENCE 1 0.0001
279 GINGIVAL PAIN 1 0.0001
280 ABSCESS 2 0.0001
281 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
282 IMPAIRED HEALING 4 0.0001
283 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
284 MENSTRUAL DISORDER 1 0.0001
285 HOT FLUSH 9 0.0001
286 ANGER 4 0.0001
287 METRORRHAGIA 2 0.0001
288 IRRITABILITY 7 0.0001
289 VAGINAL HAEMORRHAGE 5 0.0001
290 GROIN PAIN 1 0.0001
291 GRIP STRENGTH DECREASED 1 0.0001
292 MENSTRUATION IRREGULAR 3 0.0001
293 GRAND MAL CONVULSION 1 0.0001
294 PRODUCT DISTRIBUTION ISSUE 1 0.0001
295 DEFORMITY 1 0.0001
296 RASH 46 0.0001
297 DRUG INEFFECTIVE 138 0.0001
298 POST PROCEDURAL COMPLICATION 2 0.0001
299 DRUG PRESCRIBING ERROR 2 0.0001
300 AUTOIMMUNE DISORDER 1 0.0001
301 THERAPY CHANGE 1 0.0001
302 POOR QUALITY DEVICE USED 1 0.0001
303 SLUGGISHNESS 1 0.0001
304 VENTRICULAR EXTRASYSTOLES 1 0.0001
305 TENDERNESS 1 0.0001
306 URTICARIA 16 0.0001
307 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
308 RENAL PAIN 1 0.0001
309 JOINT INJURY 2 0.0001
310 NIGHT SWEATS 3 0.0001
311 ACNE 7 0.0001
312 BIPOLAR DISORDER 1 0.0001
313 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
314 INTESTINAL PERFORATION 1 0.0001
315 APPLICATION SITE PRURITUS 2 0.0001
316 POST PROCEDURAL HAEMORRHAGE 1 0.0001
317 PERIPHERAL SWELLING 13 0.0001
318 ACCIDENT 1 0.0001
319 CRYING 3 0.0001
320 GENERALISED OEDEMA 1 0.0001
321 HAIR COLOUR CHANGES 1 0.0001
322 BRAIN OEDEMA 1 0.0001
323 ECZEMA 4 0.0001
324 ADVERSE REACTION 1 0.0001
325 BLINDNESS 3 0.0001
326 PALLOR 2 0.0001
327 GINGIVAL BLEEDING 1 0.0001
328 DEVICE MECHANICAL ISSUE 1 0.0001
329 APPLICATION SITE RASH 1 0.0001
330 PROCEDURAL PAIN 2 0.0001
331 DEVICE MALFUNCTION 5 0.0001
332 SINUS TACHYCARDIA 1 0.0001
333 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
334 CONVULSION 4 0.0001
335 HYPERSOMNIA 2 0.0001
336 ACCIDENTAL UNDERDOSE 1 0.0001
337 HYPOKINESIA 1 0.0001
338 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
339 APATHY 1 0.0001
340 GASTROENTERITIS 1 0.0001
341 LABORATORY TEST ABNORMAL 2 0.0001
342 IMMUNODEFICIENCY 1 0.0001
343 DEVICE ISSUE 6 0.0001
344 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
345 THYROID DISORDER 1 0.0001
346 HYPERSENSITIVITY 12 0.0001
347 ANKLE FRACTURE 1 0.0001
348 MENINGIOMA 1 0.0001
349 HALLUCINATION, AUDITORY 1 0.0001
350 HEADACHE 39 0.0001
351 EXPIRED PRODUCT ADMINISTERED 2 0.0001
352 LIP SWELLING 2 0.0001
353 COAGULOPATHY 1 0.0001
354 FUNGAL INFECTION 2 0.0001
355 LOCAL SWELLING 1 0.0001
356 DEVICE USE ISSUE 1 0.0001
357 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
358 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
359 THIRST 1 0.0001
360 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
361 GASTROENTERITIS VIRAL 1 0.0001
362 SUICIDAL IDEATION 5 0.0001
363 SWELLING 5 0.0001
364 UNEVALUABLE EVENT 4 0.0001
365 INCREASED APPETITE 1 0.0001
366 LOWER LIMB FRACTURE 1 0.0001
367 PRODUCT QUALITY ISSUE 7 0.0001
368 SKIN FISSURES 1 0.0001
369 KIDNEY INFECTION 1 0.0001
370 COMPLICATION OF DEVICE INSERTION 1 0.0001
371 ILL-DEFINED DISORDER 3 0.0000
372 ABDOMINAL PAIN UPPER 10 0.0000
373 DERMATITIS 1 0.0000
374 MOUTH ULCERATION 1 0.0000
375 HALLUCINATION, VISUAL 1 0.0000
376 RETCHING 1 0.0000
377 APPLICATION SITE PAIN 1 0.0000
378 NO ADVERSE EVENT 8 0.0000
379 ERYTHEMA 9 0.0000
380 SKIN IRRITATION 2 0.0000
381 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
382 SLEEP DISORDER 3 0.0000
383 HYPERTENSION 9 0.0000
384 BLOOD PRESSURE FLUCTUATION 1 0.0000
385 PRESYNCOPE 1 0.0000
386 INJECTION SITE URTICARIA 1 0.0000
387 THERAPY CESSATION 2 0.0000
388 OFF LABEL USE 34 0.0000
389 ANXIETY 11 0.0000
390 RESPIRATORY TRACT INFECTION 1 0.0000
391 NERVOUSNESS 2 0.0000
392 DEAFNESS 1 0.0000
393 APPLICATION SITE ERYTHEMA 1 0.0000
394 JOINT STIFFNESS 1 0.0000
395 EAR INFECTION 1 0.0000
396 THROAT TIGHTNESS 1 0.0000
397 LIMB INJURY 1 0.0000
398 TREATMENT NONCOMPLIANCE 2 0.0000
399 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
400 VISION BLURRED 5 0.0000
401 CONDITION AGGRAVATED 11 0.0000
402 NECK PAIN 2 0.0000
403 WOUND 1 0.0000
404 DEPRESSION 8 0.0000
405 LETHARGY 2 0.0000
406 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
407 ABDOMINAL PAIN 8 0.0000
408 LIVER FUNCTION TEST ABNORMAL 1 0.0000
409 BONE PAIN 2 0.0000
410 SURGERY 2 0.0000
411 PSYCHOTIC DISORDER 1 0.0000
412 PRURITUS 13 0.0000
413 RESPIRATORY DISORDER 1 0.0000
414 LACRIMATION INCREASED 1 0.0000
415 DISCOMFORT 2 0.0000
416 EPILEPSY 1 0.0000
417 FEELING HOT 2 0.0000
418 DRUG ADMINISTRATION ERROR 1 0.0000
419 ADVERSE EVENT 3 0.0000
420 LIMB DISCOMFORT 1 0.0000
421 VISUAL IMPAIRMENT 4 0.0000
422 NERVOUS SYSTEM DISORDER 1 0.0000
423 MIGRAINE 3 0.0000
424 CYSTITIS 1 0.0000
425 ALOPECIA 6 0.0000
426 DEVICE DIFFICULT TO USE 2 0.0000
427 INSOMNIA 8 0.0000
428 SKIN DISORDER 1 0.0000
429 TYPE 2 DIABETES MELLITUS 1 0.0000
430 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
431 HAEMATURIA 1 0.0000
432 DEVICE USE ERROR 1 0.0000
433 RASH MACULAR 1 0.0000
434 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
435 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
436 VOMITING 13 0.0000
437 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
438 HYPERGLYCAEMIA 1 0.0000
439 PANIC ATTACK 1 0.0000
440 EYE SWELLING 1 0.0000
441 HALLUCINATION 2 0.0000
442 INTESTINAL OBSTRUCTION 1 0.0000
443 MUSCULAR WEAKNESS 3 0.0000
444 DIZZINESS 13 0.0000
445 PYREXIA 9 0.0000
446 DRUG DOSE OMISSION BY DEVICE 2 0.0000
447 DISEASE PROGRESSION 3 0.0000
448 THROMBOSIS 2 0.0000
449 PNEUMONIA 8 0.0000
450 DYSKINESIA 1 0.0000
451 OSTEOPOROSIS 1 0.0000
452 INFLUENZA LIKE ILLNESS 2 0.0000
453 DRUG DOSE OMISSION 4 0.0000
454 FALL 8 0.0000
455 POLLAKIURIA 1 0.0000
456 PAIN IN EXTREMITY 7 0.0000
457 HYPERHIDROSIS 3 0.0000
458 RECTAL HAEMORRHAGE 1 0.0000
459 DEVICE LEAKAGE 1 0.0000
460 MENTAL DISORDER 1 0.0000
461 CONSTIPATION 5 0.0000
462 DRY SKIN 3 0.0000
463 COLITIS ULCERATIVE 1 0.0000
464 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
465 THROAT IRRITATION 1 0.0000
466 THERAPY NON-RESPONDER 1 0.0000
467 TINNITUS 1 0.0000
468 OROPHARYNGEAL PAIN 2 0.0000
469 COGNITIVE DISORDER 1 0.0000
470 BLOOD GLUCOSE DECREASED 1 0.0000
471 INFECTION 3 0.0000
472 DRUG INTOLERANCE 2 0.0000
473 LUNG DISORDER 1 0.0000
474 HEART RATE INCREASED 2 0.0000
475 HYPOAESTHESIA 3 0.0000
476 DRY EYE 1 0.0000
477 CELLULITIS 1 0.0000
478 INFLAMMATION 1 0.0000
479 ABDOMINAL DISTENSION 2 0.0000
480 PARAESTHESIA 3 0.0000
481 DERMATITIS ATOPIC 1 0.0000
482 DEPRESSED MOOD 1 0.0000
483 DEATH 16 0.0000
484 DISTURBANCE IN ATTENTION 1 0.0000
485 MALAISE 8 0.0000
486 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
487 HAEMATOCHEZIA 1 0.0000
488 SEPSIS 2 0.0000
489 EYE PAIN 1 0.0000
490 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
491 BACK PAIN 4 0.0000
492 NASAL CONGESTION 1 0.0000
493 EMOTIONAL DISTRESS 2 0.0000
494 SUICIDE ATTEMPT 1 0.0000
495 INJECTION SITE PAIN 5 0.0000
496 NASOPHARYNGITIS 3 0.0000
497 CHEST PAIN 3 0.0000
498 PRODUCT USE ISSUE 3 0.0000
499 RHINORRHOEA 1 0.0000
500 DEEP VEIN THROMBOSIS 1 0.0000
501 PAIN 9 0.0000
502 MEMORY IMPAIRMENT 2 0.0000
503 ARTHRALGIA 6 0.0000
504 INJURY 1 0.0000
505 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
506 RESPIRATORY FAILURE 1 0.0000
507 AGITATION 1 0.0000
508 EPISTAXIS 1 0.0000
509 DIABETES MELLITUS 1 0.0000
510 BLOOD PRESSURE INCREASED 2 0.0000
511 HOSPITALISATION 2 0.0000
512 DECREASED APPETITE 3 0.0000
513 ARTHRITIS 1 0.0000
514 INJECTION SITE BRUISING 1 0.0000
515 CONFUSIONAL STATE 2 0.0000
516 SKIN EXFOLIATION 1 0.0000
517 PRODUCT STORAGE ERROR 1 0.0000
518 TACHYCARDIA 1 0.0000
519 DIARRHOEA 7 0.0000
520 WEIGHT DECREASED 3 0.0000
521 GAIT DISTURBANCE 2 0.0000
522 CONTUSION 1 0.0000
523 NAUSEA 8 0.0000
524 SYNCOPE 1 0.0000
525 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
526 FLUSHING 1 0.0000
527 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
528 SINUSITIS 1 0.0000
529 ILLNESS 1 0.0000
530 HAEMORRHAGE 1 0.0000
531 ASTHMA 1 0.0000
532 PALPITATIONS 1 0.0000
533 CHILLS 1 0.0000
534 FEELING ABNORMAL 2 0.0000
535 JOINT SWELLING 1 0.0000
536 OEDEMA PERIPHERAL 1 0.0000
537 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
538 INJECTION SITE ERYTHEMA 1 0.0000
539 PSORIASIS 1 0.0000
540 PRODUCT DOSE OMISSION ISSUE 2 0.0000
541 DRUG INTERACTION 1 0.0000
542 TREMOR 1 0.0000
543 MYALGIA 1 0.0000
544 URINARY TRACT INFECTION 1 0.0000
545 ASTHENIA 2 0.0000
546 DYSPNOEA 3 0.0000
547 ANAEMIA 1 0.0000
548 SOMNOLENCE 1 0.0000
549 INCORRECT DOSE ADMINISTERED 1 0.0000
550 FATIGUE 3 0.0000
551 COUGH 1 0.0000